| 8.43 Data as of May 17 |  +0.17 / +2.06%Today’s Change | 4.04 Today|||52-Week Range 11.24 | +40.27% Year-to-Date |
| Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma May 17 / TheStreet.com |
| Previous close | 8.26 |
| Today’s open | 8.33 |
| Day’s range | 8.19 - 8.66 |
| Volume | 611,291 |
| Average volume (3 months) | 826,739 |
| Market cap | $444.0M |
| Dividend yield | -- |
| Earnings growth (last year) | +40.85% |
| Earnings growth (this year) | -13.69% |
| Earnings growth (next 5 years) | +24.50% |
| Revenue growth (last year) | +109.86% |
| P/E ratio | NM |
| Price/Sales | 14.64 |
| Price/Book | 6.75 |
| Today’s change | Today’s % change | |
|---|---|---|
| SGYPSynergy Pharmaceutic... | +0.21 | +4.13% |
| QLTIQLT Inc | -0.12 | -1.51% |
| IDIXIdenix Pharmaceutica... | +0.27 | +6.92% |
| AMRIAlbany Molecular Res... | +0.13 | +1.19% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $21.7M |
| Annual profit (last year) | -$22.3M |
| Net profit margin | -102.81% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Edward O. Lanphier, II |
Chief Financial Officer & Executive Vice President Henry Ward Wolff, MBA, CPA |
Corporate headquarters Richmond, California |
.
